Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1524 record(s)

Req # A-2022-001007

Adverse Drug Reaction (ADR) for Pantoprazole sodium. Report number: E2B_05661818. ADRs for Lansoprazole. Report numbers: E2B_05686167, E2B_05680047.

Organization: Health Canada

78 page(s)
December 2022

Req # A-2022-001012

Adverse Drug Reactions (ADRs) for Zenhale. Report numbers: E2B_01412713, E2B_01511788, E2B_01578394, E2B_01586148, E2B_01619809, E2B_01650004.

Organization: Health Canada

143 page(s)
December 2022

Req # A-2022-001071

Adverse Drug Reaction (ADR) for . Report number: 001005758.

Organization: Health Canada

3 page(s)
December 2022

Req # A-2022-001107

Adverse Drug Reactions (ADRs). Report numbers: 001008921, 001008927, 001009522, 001009527, 001010604, 001010695, 001010703, 001011040, 001011268, 001011348.

Organization: Health Canada

58 page(s)
December 2022

Req # A-2022-001108

Adverse Drug Reactions (ADRs). Report numbers: 001011350, 001011353, 001011357, 001012623.

Organization: Health Canada

25 page(s)
December 2022

Req # A-2022-001120

Adverse Drug Reaction (ADR) for MOVAPO. Report number: 000733143.

Organization: Health Canada

2 page(s)
December 2022

Req # A-2022-001167

Adverse Drug Reaction (ADR). Report number: 001010963.

Organization: Health Canada

7 page(s)
December 2022

Req # A-2016-000579

The information regarding the interim marketing authorization that would have permitted the optional addition of vitamin and minderal nutrients to plant-based beverages. The content would have been archived on June 24, 2013.

Organization: Health Canada

174 page(s)
December 2022

Req # A-2017-000710

Any records which describe, assess or otherwise have as their chief subject techniques to edit or alter the human genome. Produced from January 1, 2015 to August 23, 2017.

Organization: Health Canada

435 page(s)
December 2022

Req # A-2018-001648

All correspondence from anyone working in the Prime Minister's Office (PMO), Privy Council Office (PCO), Public Safety Department and Department of Justice to Health Canada regarding Bonify from October 2018 to February 15, 2019.

Organization: Health Canada

194 page(s)
December 2022
Date modified: